Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $10.7950 (2.86%) ($10.7950 - $10.7950) on Fri. Feb. 26, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.13% (three month average) | RSI | 60 | Latest Price | $10.7950(2.86%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.3% a day on average for past five trading days. | Weekly Trend | BCRX advances 6.4% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Rotation from value to growth for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(45%) IBB(40%) IWO(39%) IWC(37%) IWM(37%) | Factors Impacting BCRX price | BCRX will decline at least -3.565% in a week (0% probabilities). VIXM(-21%) UUP(-15%) VXX(-8%) IGOV(-5%) TBT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.565% (StdDev 7.13%) | Hourly BBV | -0.8 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $11.03(-2.13%) | 10 Day Moving Average | $10.8(-0.05%) | 20 Day Moving Average | $10.39(3.9%) | To recent high | -9.3% | To recent low | 114.4% | Market Cap | $1.905b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |